Thin-layer chromatographic determination of urinary excretion of lactulose, simplified and applied to cystic fibrosis patients

J. A. Flick, Ronald Lee Schnaar, J. A. Perman

Research output: Contribution to journalArticle

Abstract

Urinary excretion of orally administered lactulose is used as an index of intestinal permeability. We have developed a simple thin-layer chromatographic technique for measuring lactulose in urine, using silica gel 60 plates and a propanolborate solvent system. Lactulose concentrations as low as 62.5 mg/L can be detected with high reproducibility and without interference by urinary chromogens. After oral administration, the urinary excretion of lactulose in 8 h equaled 2.33 (SD 1.86)% in 15 patients with cystic fibrosis, as compared with 0.13 (SD 0.12)% in 16 healthy subjects (P

Original languageEnglish (US)
Pages (from-to)1211-1212
Number of pages2
JournalClinical Chemistry
Volume33
Issue number7
StatePublished - 1987

Fingerprint

Lactulose
Cystic Fibrosis
Silica Gel
Oral Administration
Permeability
Healthy Volunteers
Urine

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Thin-layer chromatographic determination of urinary excretion of lactulose, simplified and applied to cystic fibrosis patients. / Flick, J. A.; Schnaar, Ronald Lee; Perman, J. A.

In: Clinical Chemistry, Vol. 33, No. 7, 1987, p. 1211-1212.

Research output: Contribution to journalArticle

@article{a35d65aed6164f06a24008708700c6a2,
title = "Thin-layer chromatographic determination of urinary excretion of lactulose, simplified and applied to cystic fibrosis patients",
abstract = "Urinary excretion of orally administered lactulose is used as an index of intestinal permeability. We have developed a simple thin-layer chromatographic technique for measuring lactulose in urine, using silica gel 60 plates and a propanolborate solvent system. Lactulose concentrations as low as 62.5 mg/L can be detected with high reproducibility and without interference by urinary chromogens. After oral administration, the urinary excretion of lactulose in 8 h equaled 2.33 (SD 1.86){\%} in 15 patients with cystic fibrosis, as compared with 0.13 (SD 0.12){\%} in 16 healthy subjects (P",
author = "Flick, {J. A.} and Schnaar, {Ronald Lee} and Perman, {J. A.}",
year = "1987",
language = "English (US)",
volume = "33",
pages = "1211--1212",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "7",

}

TY - JOUR

T1 - Thin-layer chromatographic determination of urinary excretion of lactulose, simplified and applied to cystic fibrosis patients

AU - Flick, J. A.

AU - Schnaar, Ronald Lee

AU - Perman, J. A.

PY - 1987

Y1 - 1987

N2 - Urinary excretion of orally administered lactulose is used as an index of intestinal permeability. We have developed a simple thin-layer chromatographic technique for measuring lactulose in urine, using silica gel 60 plates and a propanolborate solvent system. Lactulose concentrations as low as 62.5 mg/L can be detected with high reproducibility and without interference by urinary chromogens. After oral administration, the urinary excretion of lactulose in 8 h equaled 2.33 (SD 1.86)% in 15 patients with cystic fibrosis, as compared with 0.13 (SD 0.12)% in 16 healthy subjects (P

AB - Urinary excretion of orally administered lactulose is used as an index of intestinal permeability. We have developed a simple thin-layer chromatographic technique for measuring lactulose in urine, using silica gel 60 plates and a propanolborate solvent system. Lactulose concentrations as low as 62.5 mg/L can be detected with high reproducibility and without interference by urinary chromogens. After oral administration, the urinary excretion of lactulose in 8 h equaled 2.33 (SD 1.86)% in 15 patients with cystic fibrosis, as compared with 0.13 (SD 0.12)% in 16 healthy subjects (P

UR - http://www.scopus.com/inward/record.url?scp=0023232663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023232663&partnerID=8YFLogxK

M3 - Article

C2 - 3594850

AN - SCOPUS:0023232663

VL - 33

SP - 1211

EP - 1212

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 7

ER -